A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
Rondo Therapeutics
Avistone Biotechnology Co., Ltd.
Biogenea Pharmaceuticals Ltd.
Stella Pharma Corporation
Gene Solutions
A2 Biotherapeutics Inc.
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
Guangzhou Ruixin Biotechnological Co., LTD
VitaMed Research LLC